Bilirubin

Bilirubin is a tetrapyrrole bile pigment produced during heme catabolism that functions as a potent endogenous antioxidant. It neutralizes reactive oxygen species and peroxynitrite radicals, and epidemiological evidence links moderately elevated serum bilirubin levels to reduced risk of cardiovascular disease, type 2 diabetes, and hypertension.

Origin & History

Bilirubin is an endogenous tetrapyrrole pigment derived from the breakdown of heme in aged red blood cells, occurring naturally in humans and other mammals. It is not extracted as a supplement but is measured in serum as total bilirubin levels.

Historical & Cultural Context

There is no evidence of traditional medicinal use for bilirubin, as it is a physiological human metabolite rather than a plant-derived substance. It has not been used historically in traditional medicine systems like Ayurveda or Traditional Chinese Medicine.

Health Benefits

• May reduce the risk of cardiovascular disease, supported by genetic studies using Mendelian randomization.[1]
• Associated with reduced risk of type 2 diabetes, as shown in large cohort studies.[1]
• Potentially lowers the risk of hypertension, according to genetic associations.[1]
• May protect against chronic kidney disease, based on observational cohort data.[1]
• Exhibits antioxidant and anti-inflammatory effects in vitro, suggesting potential cytoprotective benefits.[1]

How It Works

Bilirubin is generated from heme by heme oxygenase-1 (HO-1) via the intermediate biliverdin, which is then reduced to bilirubin by biliverdin reductase. It acts as a direct scavenger of peroxyl radicals and peroxynitrite, protecting LDL cholesterol and vascular endothelium from oxidative damage. Additionally, bilirubin suppresses NADPH oxidase activity and modulates NF-κB signaling, reducing pro-inflammatory cytokine production including TNF-α and IL-6.

Scientific Research

Clinical trials and genetic studies have linked higher bilirubin levels to various health benefits, including reduced risks of cardiovascular and metabolic diseases (PMID: 35727760). However, no RCTs administer bilirubin directly as therapy, focusing instead on measurement or genetic modulation (PMID: 40498757).

Clinical Summary

Mendelian randomization studies using the UGT1A1 gene variant (which raises serum bilirubin) as an instrumental variable have provided causal evidence that higher bilirubin reduces cardiovascular disease risk by approximately 6–11% per unit increase. Large prospective cohort studies involving tens of thousands of participants have associated serum bilirubin levels in the upper normal range (0.6–1.2 mg/dL) with a 20–30% lower incidence of type 2 diabetes compared to lower levels. Cross-sectional and longitudinal studies also report inverse associations between bilirubin and hypertension risk, though confounding remains a limitation in observational designs. Overall, the evidence is promising but largely associative; no randomized controlled trials have tested exogenous bilirubin supplementation in humans.

Nutritional Profile

Bilirubin is not a nutrient or dietary compound; it is an endogenous tetrapyrrole pigment produced as the catabolic end-product of heme degradation. It is not obtained through food intake and therefore has no conventional nutritional profile. Key biochemical details: Normal serum total bilirubin ranges from approximately 0.1–1.2 mg/dL (1.7–20.5 µmol/L), comprising unconjugated (indirect) bilirubin (~0.1–1.0 mg/dL, bound to albumin, lipophilic) and conjugated (direct) bilirubin (~0.0–0.3 mg/dL, water-soluble glucuronide form). Bioactive properties: Unconjugated bilirubin is a potent lipophilic antioxidant; at nanomolar concentrations it scavenges peroxyl radicals and protects membrane lipids from oxidation, with a catalytic cycle involving biliverdin reductase that regenerates bilirubin from biliverdin. Mildly elevated serum unconjugated bilirubin (as seen in Gilbert syndrome, ~1.5–4.0 mg/dL) is associated with reduced oxidative stress biomarkers including lower plasma malondialdehyde and oxidized LDL. Bilirubin also exhibits anti-inflammatory activity by suppressing NF-κB signaling and inhibiting NADPH oxidase activity, and has anti-proliferative effects on vascular smooth muscle cells. It contains no macronutrients (no protein, carbohydrate, fat, or fiber), no vitamins, and no minerals. Its molecular formula is C₃₃H₃₆N₄O₆ (molecular weight 584.66 g/mol). Bioavailability is not applicable in the dietary sense; endogenous production is approximately 250–400 mg/day in adults, derived primarily from senescent erythrocyte hemoglobin (~80%) and hepatic hemoproteins (~20%). It is metabolized hepatically via UGT1A1 (UDP-glucuronosyltransferase 1A1) conjugation and excreted in bile.

Preparation & Dosage

No clinically studied dosages exist for bilirubin administration, as it is not used therapeutically in an extract, powder, or standardized form. Studies measure endogenous levels or use interventions like phototherapy to reduce it. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Curcumin, Resveratrol, Omega-3 fatty acids, CoQ10, N-acetylcysteine

Safety & Interactions

Elevated serum bilirubin above approximately 2.5 mg/dL (jaundice threshold) can indicate underlying hepatic or hemolytic pathology and is not inherently beneficial at those levels. In neonates, severely elevated unconjugated bilirubin can cross the blood-brain barrier and cause kernicterus, a neurotoxic condition requiring medical intervention. Bilirubin may interfere with laboratory assays for cholesterol, creatinine, and glucose by causing spectrophotometric interference, potentially skewing diagnostic results. No established drug interactions exist for endogenous bilirubin, but drugs that displace bilirubin from albumin binding sites — such as sulfonamides, salicylates, and some NSAIDs — can raise free unconjugated bilirubin and pose risk particularly in neonates or those with Gilbert syndrome.